jain.com

January 2024 Bitmain agreement exercised options balance

Company: IREN

Subject kind
acquisition
Statement date
2024-11-25
Promised by
2025-01-31
Promised amount
15900000.0 USD
Current status
outcome unconfirmed

What the later record shows

Outcome not yet confirmed

The December 2024 report only repeats that the $15.9 million balance is due in January 2025. No later passage confirms it was paid.

“The remaining balance of $15.9 million in relation to the exercised options to purchase 17,950 miners is due in January 2025.”
2025-03-19 · iren 8-K exhibit (irenlimited-exx992dec2024x.htm) View cached copy (2026-10-18)Live source ↗

Checked October 24, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.

The claim, verbatim

The remaining $15.9 million for the exercised options to buy 17,950 S21 Pro miners under the January 2024 Bitmain agreement is due in January 2025.

Source (primary)

iren 8-K exhibit (irisenergylimited-exx994se.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-24)Live source ↗

Quote: “The remaining balance of $15.9 million in relation to the exercised options to purchase 17,950 miners is due in January 2025”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms iren 8-K exhibit (irisenergylimited-exx994se.htm)

Quote: “The remaining balance of $15.9 million in relation to the exercised options to purchase 17,950 miners is due in January 2025”

View cached copy (2026-10-24)Live source ↗

Record of changes

October 24, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 24, 2026 — outcome unconfirmed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.